Philips Medical Systems Incurs Second Warning Letter Since August
This article was originally published in The Gray Sheet
Executive Summary
Corrective actions related to a warning letter Philips Medical Systems received Oct. 16 will be addressed during a meeting between the company and FDA the week of Nov. 3